| The
Clinical Diagnosis of Deep Venous Thrombosis: Integrating
Incidence, Risk Factors, and Symptoms and Signs |
| |
Susan R. Kahn
Arch Intern Med 1998; 158: 2315-23.[Full
Text] [PDF] |
Thrombus Formation on Atherosclerotic Plaques: Pathogenesis
and Clinical Consequences |
| |
Ursula Rauch, Julio I. Osende, Valentin
Fuster, et al.
Ann Intern Med 2001; 134:224-38. [Full
Text] [PDF] |
Relative
Impact of Risk Factors for Deep Vein Thrombosis and
Pulmonary Embolism: A Population-Based Study
|
| |
John A. Heit, Michael O"Fallon,
Tanya M. Petterson, et al.
Arch Intern Med 2002; 162:1245-8.
[Full Text] [PDF]
|
Strategies
to Improve Compensation for Pharmaceutical Care Services
|
| |
Marialice S. Bennett, Dawn Blank,
Janice Bopp, et al.
J Am Pharm Assoc 2000; 40:747-55. [PDF] |
|
| Readings
from the American College of Chest Physicians Sixth
Consensus Conference on Antithrombotic Therapy |
| |
[Chest, volume 119, number 1 (supplement),
January 2001] |
The following reading materials are from the American
College of Chest Physicians (ACCP) consensus guidelines
that are the premiere authoritative source for current
treatment strategies.
These readings can be downloaded from the ACCP web
site (http://www.chestjournal.org/content/vol119/1_suppl).
You can purchase a hardcopy of the entire guideline
directly from ACCP Consensus Conference Statement
and Practice Guidelines which may be ordered from
ACCP Member Services Division at (847) 498-1400 or
(800) 343-2227 ; Fax : (847) 498-5460. The cost of
the printed 370 page guideline is $18.00. |
The
Sixth (2000) ACCP Guidelines for Antithrombotic Therapy
for Prevention and Treatment of Thrombosis |
| |
Jack Hirsh, James E. Dalen, and Gordon
Guyatt
Chest 119: 1S-2S. [Full
Text] [PDF]
|
Grades
of Recommendation for Antithrombotic Agents |
| |
Gordon Guyatt, Holger Schunëmann,
Deborah Cook, Roman Jaeschke, Stephen Pauker, and
Heiner Bucher
Chest 119: 3S-7S. [Full
Text] [PDF] |
Oral
Anticoagulants: Mechanism of Action, Clinical Effectiveness,
and Optimal Therapeutic Range |
| |
Jack Hirsh, James E. Dalen, David
R. Anderson, Leon Poller, Henry Bussey, Jack Ansell,
and Daniel Deykin
Chest 119: 8S-21S. [Full
Text] [PDF]
|
Managing
Oral Anticoagulant Therapy |
| |
Jack Ansell, Jack Hirsh, James Dalen,
Henry Bussey, David Anderson, Leon Poller, Alan Jacobson,
Daniel Deykin, and David Matchar
Chest 119: 22S-38S. [Full
Text] [PDF] |
Platelet-Active Drugs : The
Relationships Among Dose, Effectiveness, and Side
Effects |
| |
Carlo Patrono, Barry Coller, James
E. Dalen, Garret A. FitzGerald, Valentin Fuster, Michael
Gent, Jack Hirsh, and Gerald Roth
Chest 119: 39S-63S. [Full
Text] [PDF]
|
Heparin and Low-Molecular-Weight
Heparin Mechanisms of Action, Pharmacokinetics, Dosing,
Monitoring, Efficacy, and Safety |
| |
Jack Hirsh, Theodore E. Warkentin,
Stephen G. Shaughnessy, Sonia S. Anand, Jonathan L.
Halperin, Robert Raschke, Christopher Granger, E.
Magnus Ohman, and James E. Dalen
Chest 119: 64S-94S. [Full
Text] [PDF]
|
New Anticoagulant Drugs |
| |
Jeffrey I. Weitz and Jack Hirsh
Chest 119: 95S-107S. [Full
Text] [PDF] |
Hemorrhagic Complications of Anticoagulant Treatment |
| |
Mark N. Levine, Gary Raskob, Seth
Landefeld, and Clive Kearon
Chest 119: 108S-121S. [Full
Text] [PDF]
|
Prevention of Venous Thromboembolism |
| |
William H. Geerts, John A. Heit,
G. Patrick Clagett, Graham F. Pineo, Clifford W. Colwell,
Frederick A. Anderson, Jr., and H. Brownell Wheeler
Chest 119: 132S-175S. [Full
Text] [PDF]
|
Antithrombotic Therapy for Venous
Thromboembolic Disease |
| |
Thomas M. Hyers, Giancarlo Agnelli,
Russell D. Hull, Timothy A. Morris, Michel Samama,
Victor Tapson, and John G. Weg
Chest 119: 176S-193S. [Full
Text] [PDF]
|
Antithrombotic Therapy in Atrial
Fibrillation |
| |
Gregory W. Albers, James E. Dalen,
Andreas Laupacis, Warren J. Manning, Palle Petersen,
and Daniel E. Singer
Chest 119: 194S-206S. [Full
Text] [PDF]
|
Antithrombotic Therapy in Valvular
Heart Disease |
| |
Deeb N. Salem, Denise Hartnett Daudelin,
Herbert J. Levine, Stephen G. Pauker, Mark H. Eckman,
and Joshua Riff
Chest 119: 207S-219S. [Full
Text] [PDF]
|
Antithrombotic Therapy in Patients
With Mechanical and Biological Prosthetic Heart Valves
|
| |
Paul D. Stein, Joseph S. Alpert,
Henry I. Bussey, James E. Dalen, and Alexander G.G.
Turpie
Chest 119: 220S-227S. [Full
Text] [PDF]
|
Antithrombotic Agents in Coronary
Artery Disease |
| |
John A. Cairns, Pierre Théroux,
H. Daniel Lewis, Jr., Michael Ezekowitz, and Thomas
W. Meade
Chest 119: 228S-252S. [Full
Text] [PDF]
|
Antithrombotic Therapy in Peripheral
Arterial Occlusive Disease |
| |
Mark R. Jackson and G. Patrick Clagett
Chest 119: 283S-299S. [Full
Text] [PDF]
|
Antithrombotic and Thrombolytic
Therapy for Ischemic Stroke |
| |
Gregory W. Albers, Pierre Amarenco,
J. Donald Easton, Ralph L. Sacco, and Philip Teal
Chest 119: 300S-320S. [Full
Text] [PDF] |
Thrombosis
Prevention and Management in the Older Adult
